Dividend Power Score
A single, comprehensive score designed to measure the true strength of a company’s dividend.
This score combines three essential pillars of dividend quality:
Consistency – Measures how reliable the dividend has been over time, focusing on payment history, stability, and the absence of cuts or suspensions.
Payability – Assesses the company’s financial ability to sustain its dividend, taking into account cash flow, earnings coverage, balance sheet strength, and overall financial health.
Growth – Evaluates the long-term growth of both the dividend and the company’s share price, highlighting businesses that consistently increase payouts while creating shareholder value.
Higher scores identify companies that have historically delivered dependable income alongside sustained dividend growth and long-term capital appreciation.
Company Overview
TerrAscend Corp. is a North America–focused cannabis company engaged in the cultivation, processing, manufacturing, and retail distribution of cannabis products. The company operates within the regulated medical and adult-use cannabis industries, with revenue primarily driven by branded product sales and vertically integrated retail operations. TerrAscend’s activities span wholesale cannabis production, branded consumer packaged goods, and direct-to-consumer retail through company-owned dispensaries.
The company serves medical and adult-use cannabis consumers across several U.S. states, targeting regulated markets with limited license structures. TerrAscend positions itself as a multi-state operator with a focus on premium branding, operational scale, and disciplined capital allocation. Founded in 2014 and originally based in Canada, the company evolved from a Canadian cannabis issuer into a U.S.-centric operator as U.S. state legalization expanded, gradually divesting non-core Canadian exposure to concentrate on American markets.
Business Operations
TerrAscend generates revenue through vertically integrated cannabis operations organized around cultivation and manufacturing assets, wholesale distribution, and retail dispensaries. Key operating platforms and brands include The Apothecarium retail dispensary chain and branded product lines such as Kind Tree and Gage Cannabis, which are sold through both company-owned stores and third-party dispensaries where permitted.
The company operates licensed cultivation and processing facilities and retail locations across multiple U.S. states, with a strategic emphasis on limited-license jurisdictions. Subsidiaries and operating entities include State Flower, Ilera Healthcare, and Gage Cannabis, which support state-level compliance and localized branding. TerrAscend controls cultivation facilities, manufacturing labs, and retail real estate assets, enabling vertical integration in most of its core markets.
Strategic Position & Investments
TerrAscend’s strategy centers on expanding scale in existing core markets, improving operating efficiency, and strengthening its portfolio of consumer brands. Growth initiatives have focused on increasing retail footprint density, expanding cultivation capacity where demand supports it, and enhancing margins through vertical integration. The company has historically pursued selective acquisitions to enter or strengthen positions in attractive U.S. states, including the acquisition of Gage Cannabis, which significantly expanded its presence in Michigan.
The company has invested in product innovation across flower, vape, and derivative categories, aligning with evolving consumer preferences in mature cannabis markets. TerrAscend’s strategic direction emphasizes disciplined capital deployment, debt reduction, and cash flow generation rather than aggressive geographic expansion. Data regarding future acquisitions or large-scale investments beyond announced transactions is inconclusive based on available public sources.
Geographic Footprint
TerrAscend’s operations are primarily concentrated in the United States, with licensed activities in Pennsylvania, New Jersey, Maryland, Michigan, and California. These states represent the company’s core revenue-generating markets, with particular emphasis on the Mid-Atlantic and Midwest regions. The company’s retail presence is anchored by The Apothecarium dispensaries, while cultivation and manufacturing assets are co-located within state regulatory frameworks.
The company is headquartered in Canada and is listed on both the Toronto Stock Exchange and the U.S. OTC market, reflecting its Canadian corporate structure and U.S.-based operations. TerrAscend no longer maintains material operating exposure outside North America, and international cannabis investments are not a current strategic focus.
Leadership & Governance
TerrAscend is led by an executive team with experience in cannabis operations, capital markets, and regulated industries. The leadership emphasizes operational discipline, brand development, and compliance-driven growth within U.S. state frameworks. The company operates under a board-led governance structure consistent with public company requirements in Canada and the United States.
Key executives include:
- Jason Wild – Executive Chairman
- Jason Ackerman – Chief Executive Officer
- Keith Stauffer – Chief Financial Officer
- Jason Lewis – Chief Operating Officer
Information regarding executive roles and titles is based on public disclosures; however, minor variations across reporting periods may exist. Data inconclusive based on available public sources for any unannounced leadership changes.